$CAHO
Caro Holdings Inc.

2024 Q3 Form 10-Q Financial Statement

#000164033424001205 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $5.626K $18.82K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $36.91K $32.44K $50.00K
YoY Change 98.44% -35.12% 373.04%
% of Gross Profit
Research & Development $0.00 $0.00 $63.65K
YoY Change -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization $9.220K $9.210K
YoY Change
% of Gross Profit
Operating Expenses $46.13K $41.65K $112.2K
YoY Change -29.9% -62.87% 961.1%
Operating Profit -$40.50K -$22.83K -$112.2K
YoY Change -38.45% -79.65% 961.1%
Interest Expense $48.34K $24.64K $38.69K
YoY Change -54.54% -36.32%
% of Operating Profit
Other Income/Expense, Net -$27.66K -$23.59K -$34.07K
YoY Change -76.07% -30.74%
Pretax Income -$68.16K -$46.43K -$146.2K
YoY Change -62.43% -68.25% 1283.6%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$68.16K -$46.43K -$146.2K
YoY Change -62.43% -68.25% 1283.33%
Net Earnings / Revenue -1211.43% -246.73%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 36.71M shares 36.51M shares
Diluted Shares Outstanding 36.79M shares 36.51M shares 60.00M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.54K $5.820K $0.00
YoY Change 115.25%
Cash & Equivalents $26.54K $5.815K $959.00
Short-Term Investments
Other Short-Term Assets $161.9K $161.9K
YoY Change 1195.2%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $245.1K $219.7K $14.58K
YoY Change 316.3% 1407.14% 124.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $230.4K $239.6K $258.0K
YoY Change -10.71% -7.14%
TOTAL ASSETS
Total Short-Term Assets $245.1K $219.7K $14.58K
Total Long-Term Assets $230.4K $239.6K $258.0K
Total Assets $475.4K $459.3K $272.6K
YoY Change 50.04% 68.51% 4090.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.58K $61.06K $100.0K
YoY Change -6.66% -38.94% 448.85%
Accrued Expenses $59.98K $49.19K $10.00K
YoY Change 227.76% 391.9%
Deferred Revenue
YoY Change
Short-Term Debt $856.1K $797.6K $380.0K
YoY Change 43.74% 109.89%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.039M $970.5K $548.2K
YoY Change 41.67% 77.03% 1302.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.039M $970.5K $548.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.039M $970.5K $548.2K
YoY Change 41.67% 77.03% 1302.86%
SHAREHOLDERS EQUITY
Retained Earnings -$1.218M -$1.149M -$710.2K
YoY Change 36.56% 61.85% 225.76%
Common Stock $372.00 $365.00 $600.00
YoY Change 56.96% -39.17% 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$563.9K -$511.2K -$275.7K
YoY Change
Total Liabilities & Shareholders Equity $475.4K $459.3K $272.6K
YoY Change 50.04% 68.51% 4090.32%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$68.16K -$46.43K -$146.2K
YoY Change -62.43% -68.25% 1283.33%
Depreciation, Depletion And Amortization $9.220K $9.210K
YoY Change
Cash From Operating Activities -$15.77K -$34.59K -$43.74K
YoY Change -87.78% -20.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.870K $0.00 -$10.00K
YoY Change -89.2% -100.0%
Cash From Investing Activities -$1.870K $0.00 -$7.305K
YoY Change -89.2% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 54.50K $20.00K $53.90K
YoY Change -64.12% -62.89% 10680.0%
NET CHANGE
Cash From Operating Activities -15.77K -$34.59K -$43.74K
Cash From Investing Activities -1.870K $0.00 -$7.305K
Cash From Financing Activities 54.50K $20.00K $53.90K
Net Change In Cash 36.86K -$14.98K -$1.320K
YoY Change 570.18% 1034.77%
FREE CASH FLOW
Cash From Operating Activities -$15.77K -$34.59K -$43.74K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20794 usd
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
0 usd
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
105 usd
CY2024Q2 us-gaap Other Receivables
OtherReceivables
332 usd
CY2024Q2 us-gaap Notes Receivable Net
NotesReceivableNet
43954 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
43954 usd
CY2024Q2 caro Loans Notes Receivable And Financing Receivable Current
LoansNotesReceivableAndFinancingReceivableCurrent
5000 usd
CY2024Q1 caro Loans Notes Receivable And Financing Receivable Current
LoansNotesReceivableAndFinancingReceivableCurrent
5000 usd
CY2024Q2 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
161895 usd
CY2024Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
161895 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
219741 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
233716 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
239572 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
248786 usd
CY2024Q2 us-gaap Assets
Assets
459313 usd
CY2024Q1 us-gaap Assets
Assets
482502 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
61059 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
81559 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
49185 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
37884 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62712 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
63360 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
28900 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
28900 usd
CY2024Q2 us-gaap Revenues
Revenues
18817 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24785 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3342 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
4497 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
37680 usd
CY2024Q2 caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
3155 usd
CY2023Q2 caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
7504 usd
CY2024Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9214 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2024Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
0 usd
CY2023Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
63654 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
41651 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
112180 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22834 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-112180 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
24636 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
38689 usd
CY2024Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
787 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
180 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
255 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4443 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23594 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34066 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146246 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-46428 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-146246 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-248 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46676 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-150896 usd
CY2024Q2 caro Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2023Q2 caro Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36505000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60000000 shares
CY2024Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001678105
CY2024Q2 dei Amendment Flag
AmendmentFlag
false
CY2024Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36505000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36505000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36505000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36505000 shares
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity File Number
EntityFileNumber
333-212268
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
CARO HOLDINGS INC.
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-2109546
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
7 Castle Street
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Sheffield
CY2024Q2 dei Entity Address Country
EntityAddressCountry
GB
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
S3 8LT
CY2024Q2 dei City Area Code
CityAreaCode
786
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
755-3210
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36705000 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5815 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
9 usd
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
2745 usd
CY2024Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
1959 usd
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
768666 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
735332 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
970522 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
947035 usd
CY2024Q2 us-gaap Liabilities
Liabilities
970522 usd
CY2024Q1 us-gaap Liabilities
Liabilities
947035 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
365 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
365 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
645958 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
645958 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1149379 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1102951 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8153 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7905 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-511209 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-464533 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
459313 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
482502 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46428 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4650 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-464533 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-248 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-46428 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-511209 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-124762 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4650 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-146246 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-275658 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
46428 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
146246 usd
CY2024Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9214 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2024Q2 caro Gain Loss On Conertible Notes
GainLossOnConertibleNotes
-13333 usd
CY2023Q2 caro Gain Loss On Conertible Notes
GainLossOnConertibleNotes
-33333 usd
CY2024Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
787 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
180 usd
CY2024Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
256 usd
CY2023Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
97 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-105 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20414 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
64097 usd
CY2024Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
11302 usd
CY2023Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5355 usd
CY2024Q2 caro Increase Decrease Management Salary Payable
IncreaseDecreaseManagementSalaryPayable
-657 usd
CY2023Q2 caro Increase Decrease Management Salary Payable
IncreaseDecreaseManagementSalaryPayable
0 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34587 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43739 usd
CY2024Q2 caro Payments To Acquire Promissory Loans Receivable
PaymentsToAcquirePromissoryLoansReceivable
0 usd
CY2023Q2 caro Payments To Acquire Promissory Loans Receivable
PaymentsToAcquirePromissoryLoansReceivable
7305 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7305 usd
CY2024Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3900 usd
CY2024Q2 caro Proceeds From Issuance Of Convertible Notes
ProceedsFromIssuanceOfConvertibleNotes
20000 usd
CY2023Q2 caro Proceeds From Issuance Of Convertible Notes
ProceedsFromIssuanceOfConvertibleNotes
50000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53900 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-392 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4176 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14979 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1320 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20794 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2279 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5815 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
959 usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q2 caro Operating Expenses Paid By Related Parties
OperatingExpensesPaidByRelatedParties
0 usd
CY2023Q2 caro Operating Expenses Paid By Related Parties
OperatingExpensesPaidByRelatedParties
4684 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1149379 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
768666 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
266666 shares
CY2024Q2 caro Loans Notes Receivable And Financing Receivable Current
LoansNotesReceivableAndFinancingReceivableCurrent
5000 usd
CY2024Q2 caro Interest Revenue
InterestRevenue
0.08 pure
CY2023Q1 caro Loans Notes Receivable And Financing Receivable Current
LoansNotesReceivableAndFinancingReceivableCurrent
5000 usd
CY2024Q2 caro Loans Notes Interest Receivable And Financing Receivable
LoansNotesInterestReceivableAndFinancingReceivable
118 usd
CY2023Q1 caro Loans Notes Interest Receivable And Financing Receivable
LoansNotesInterestReceivableAndFinancingReceivable
19 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36505000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36505000 shares

Files In Submission

Name View Source Status
0001640334-24-001205-index-headers.html Edgar Link pending
0001640334-24-001205-index.html Edgar Link pending
0001640334-24-001205.txt Edgar Link pending
0001640334-24-001205-xbrl.zip Edgar Link pending
caro-20240630.xsd Edgar Link pending
caro_10q.htm Edgar Link pending
caro_ex311.htm Edgar Link pending
caro_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
caro-20240630_def.xml Edgar Link unprocessable
caro-20240630_lab.xml Edgar Link unprocessable
caro-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
caro_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
caro-20240630_cal.xml Edgar Link unprocessable